US8068821060 - Common Stock
SCHNITZER STEEL INDS INC-A
NASDAQ:SCHN (8/31/2023, 7:18:19 PM)
After market: 33.2 0 (0%)33.2
-0.19 (-0.57%)
Schnitzer Steel Industries, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company is headquartered in Boston, Massachusetts and currently employs 3,471 full-time employees. The firm is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The firm also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).
SCHNITZER STEEL INDS INC-A
22 Boston Wharf Road, 7Th Floor
Boston MASSACHUSETTS 97201
P: 15032249900.0
CEO: Tamara L. Lundgren
Employees: 3471
Website: https://www.schnitzersteel.com/
Schnitzer Steel Industries (SCHN) announced on Wednesday its new name, Radius Recycling.SCHN added that it will change its Nasdaq ticker to RDUS in September 2023.Press Release
Major indexes rebounded strongly and many stocks flashed buy signals.
Here you can normally see the latest stock twits on SCHN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: